EDGAR Filing Documents for 9999999995-20-002500

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-20-002500

Accepted

2020-09-21 15:28:04

Documents

Effectiveness Date

2020-09-18

Registration Form

POS AM

Reference AccNo

0001104659-20-104500

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	605
	Complete submission text file	9999999995-20-002500.txt		1906

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: EFFECT | Act: 33 | File No.: 333-239923 | Film No.: 201186261
SIC: 2834 Pharmaceutical Preparations